IL15 and cancer: Nonetheless, although IL-15 armored CAR-NK cells exhibit better anti-cancer activity, IL-15 secreted by these cells may induce severe systemic toxicities (Christodoulou et al., 2021a), underscoring the need for providing more specific cytokine signals to avoid their systemic toxicities.